Male pattern hair loss
affects a large portion of the male population according to The International Society of Hair Restoration Surgery.
Finasteride (Propecia) is a prescription medication that is FDA approved to treat male pattern hair loss
. Propecia works by inhibiting the activity of the enzyme 5-alpha-reductase, which stops the conversion of testosterone into dihydrotesto-sterone (DHT).
A control group of 29 men who had male pattern hair loss
but had never taken finasteride nor had any history of psychiatric problems were also interviewed.
The data clearly highlight the positive effects of PRP injections on male pattern hair loss
and absence of major side effects.
Biopharmaceutical company KYTHERA Biopharmaceuticals (NasdaqGS:KYTH) disclosed on Tuesday that it has submitted an Investigational New Drug Application (IND) to the US Food and Drug Administration (FDA) for KYTH-105 (setipiprant) for treatment of androgenetic alopecia (AGA), or male pattern hair loss
M2 PHARMA-September 23, 2015-KYTHERA submits KYTH-105's IND to the US FDA for the development of KYTH-105 for male pattern hair loss